Peroxisome
Proliferator Activated Receptors (PPARs) attract great attention in
light of the wide spectrum of genes of biological and medical relevance
identified as under their control. As a consequence, our knowledge
of the role of these receptors in physiology and pathology continues
to grow at a fast pace and PPARs have become an interesting target
for the treatment of many pathological conditions, including diabetes
and atherosclerosis.

This volume provides an authoritative view of the current clinical
and scientific developments within this evolving area of study.